Punicalagin and ellagic acid containing Punica granatum L. fruit rind extract prevents vincristine-induced neuropathic pain in rats: an in silico and in vivo evidence of GABAergic action and cytokine inhibition.

Autor: Jain V; Department of Pharmaceutical Sciences, Mohanlal Sukhadia University, Udaipur, Rajasthan, India.; Department of Pharmacy, Banasthali University, Banasthali, India., Pareek A; Department of Pharmacy, Banasthali University, Banasthali, India., Bhardwaj YR; Department of Pharmacy, Banasthali University, Banasthali, India., Sinha SK; Department of Pharmaceutical Sciences, Mohanlal Sukhadia University, Udaipur, Rajasthan, India., Gupta MM; School of Pharmacy, Faculty of Medical Sciences, The University of the West Indies, St Augustine, Trinidad & Tobago, West Indies., Singh N; Department of Pharmaceutical Sciences and Drug Research, Punjabi University, Patiala, India.
Jazyk: angličtina
Zdroj: Nutritional neuroscience [Nutr Neurosci] 2022 Oct; Vol. 25 (10), pp. 2149-2166. Date of Electronic Publication: 2021 Aug 09.
DOI: 10.1080/1028415X.2021.1954293
Abstrakt: Objectives: We aimed to investigate the protective potential of Punica granatum L. fruit rind extract (PFE) containing punicalagin (10.3% W/W), ellagic acid (EA) (2.7%W/W) in vincristine (75 µg/kg i.p.)- induced neuropathic pain in Wistar rats. Methods: Docking simulation studies were done on the three-dimensional (3D) structure of the GABA A and PPAR γ receptor for the binding of EA as well as punicalagin docking studies on TNF-α, and IL-6. The Present Study conceptualized a test battery to evaluate the behavioral, biochemical and histological changes. Results: Vincristine -induced significant cold allodynia, mechanical hyperalgesia, and functional deficit on 12th and 21st days. It also increased in the levels of TNF-α (Tumor necrosis factor-α), IL-6 (Interleukin-6), and MPO (Myeloperoxidase). Administration of PFE (100 and 300 mg/kg, p.o.), EA (50 mg/kg), and gabapentin (100 mg/kg) attenuated Vincristine-induced behavioral and biochemical changes significantly ( P < .05). PFE showed better antinociceptive activity to EA. The histopathological evaluation also revealed the protective effects of PFE. Pretreatment of bicuculline (selective antagonist of GABAA receptors) reversed antinociceptive action of PFE, but administration of γ aminobutyric acid potentiated the action of PFE. PPAR-γ antagonist BADGE did not modify the effect of PFE. Docking results revealed that EA properly positioned into GABA and PPARγ binding site and acts as a partial agonist. Docking score of Punicalagin found to be - 9.02 kcal/mol and - 8.32 kcal/mol on IL-6 and TNFα respectively. Discussion : Conclusively, the attenuating effect of PFE may be attributed to the GABAergic system, cytokine inhibition, and anti-inflammatory activities.
Databáze: MEDLINE
Nepřihlášeným uživatelům se plný text nezobrazuje